TOKYO—The antiviral drug remdesivir appeared to have an effect in American cruise passengers treated for the novel coronavirus in Japan, although data are limited, according to a doctor sent to Tokyo by the U.S. government. Rear Adm. Richard Childs, an assistant surgeon general and lung specialist at the National Institutes of Health, said 14 Americans who contracted the virus on the Diamond Princess cruise ship and were treated at Japanese hospitals received the experimental drug from Gilead Sciences Inc....

Source: Wall Street Journal March 13, 2020 10:45 UTC